Detalles de la búsqueda
1.
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Am J Hematol
; 98(10): 1588-1597, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470365
2.
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Am J Hematol
; 98(10): 1579-1587, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37466271
3.
[Simultaneous determination of donafenib and its N-oxide metabolite in human plasma by liquid chromatography-tandem mass spectrometry].
Yao Xue Xue Bao
; 52(3): 443-8, 2017 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-29979858
4.
Clinical Outcomes of Combined Transcranial and Endoscopic Transnasal Approaches in the Management of Cranionasal Communicating Tumors.
Neuro Endocrinol Lett
; 44(6): 410-417, 2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37776558
Resultados
1 -
4
de 4
1
Próxima >
>>